Identification | Back Directory | [Name]
5-[3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-1H-isoquinoline-2-carbaldehyde | [CAS]
61563-18-6 | [Synonyms]
Soquinolol 5-[3-(tert-Butylamino)-2-hydroxypropoxy]-3,4-dihydro-2(1H)-isoquinolinecarbaldehyde 5-[3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-1H-isoquinoline-2-carbaldehyde 2(1H)-Isoquinolinecarboxaldehyde, 5-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro- | [EINECS(EC#)]
262-844-8 | [Molecular Formula]
C17H26N2O3 | [MDL Number]
MFCD00865950 | [MOL File]
61563-18-6.mol | [Molecular Weight]
306.4 |
Hazard Information | Back Directory | [Uses]
Soquinolol is a β adrenergic receptor antagonist. Soquinolol plays an important role in cardiac failure research[1]. | [References]
[1] J Gries, et al. Pharmacological characterization of the new highly potent beta-adrenergic receptor blocker soquinolol. Arzneimittelforschung. 1988 Sep;38(9):1271-9. PMID:2906243 |
|
Company Name: |
Leancare Ltd.
|
Tel: |
+33 962096793 |
Website: |
www.leancare.co.uk |
|